Products may be purchased only by qualified researchers or authorized personnel for legitimate in-vitro research
The agency highlighted several issues: No FDA-approved component: FDA noted that none of the evaluated CJC-1295-related substances are components of an FDA-approved drug
Da: GLP-1RA h tr gim vim trong cc bnh l da liu nh vy nn
The background: In September 2023, the FDA placed nineteen peptides, including BPC-157 and TB-500, into Category 2 of its 503A bulk drug substances policy, citing safety concerns
For general digestive health, certain Lactobacillus and Bifidobacterium species are commonly used
Meanwhile, the APC statement notes, Novo Nordisk and Eli Lilly have sued compounding companies in several states, questioning, among other things, the purity and potency of some compounded products